Innovation and Value in Health Care

NEHI’s research and analysis focuses on assessing the impact of highly innovative novel therapies on the U.S. health care system, and potential solutions to ensure timely patient access, affordability, and sustainable health insurance coverage. NEHI’s agenda on value and innovation is also aimed at systematic improvement in the use of medicines through improved patient medication adherence and medication management. Prior NEHI research on patient medication adherence is widely cited. Current NEHI projects focus on unique payment and insurance coverage challenges raised by very highly innovative, "next generation" therapies, as well as access and affordability to these therapies for financially vulnerable patients.

Filter Initiatives By Theme:

Initiatives

Showing : 1–10 of 29

NEHI Member Spotlight

See our full member directory

Eli Lilly and Company
American Diabetes Association
Massachusetts Medical Society
Partners HealthCare System
HIMSS
Epstein Becker & Green, P.C.
Foley Hoag, LLP
Cedars-Sinai
AdvaMed
Goodyear Tire & Rubber Company
Alnylam Pharmaceuticals
Dana-Farber Cancer Institute
The Ohio State University College of Nursing
California Life Sciences Association
Caregivers Action Network
Bristol-Myers Squibb
Spark Therapeutics
Project HOPE
DePuy Synthes
Sarepta Therapeutics
Back to Top